A RANDOMIZED CONTROLLED TRIAL ON THERAPEUTIC EFFICACY OF SIDDHA HERBAL FORMULATIONAAVARAI KIRUTHAMIN THE TREATMENT OF MADHUMEGA AVATHAIGAL(VII)-DIABETIC PERIPHERAL NEUROPATHY COMPLICATION OF NON-INSULIN DEPENDENT(TYPE-II)DIABETES MELLITUS - MADHUMEGAM

AYOTHIDOSS PANDITHAR HOSPITA0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•BLOOD SUGAR FASTING >126 mg/dl and >200,post prandial blood sugar >200 and <350 mg/dl,GLYCATED HAEMOGLOBIN > 7% AND < 11%,DIABETES PERIPHERAL NEUROPATHY MADHUMEGA AVATHAIGAL,PATIENT WHO IS ALREADY UNDER SIDDHA MEDICATION FOR MADHUMEGAM,DIABETES WITH HYPERTENSION.

•AGE BETWEEN 30 YEARS TO 65 YEARS BOTH GENDER,GLYCATED HAEMOGLOBIN < 7% AND > 11%,
•INSULIN DEPENDENT DIABETES MELLITUS,SECONTARY DIABETES MELLITUS,PREGNANT WOMEN AND PLANNING TO BE PREGNANT WITHIN 3 MONTHS,GESTATIONAL DIABETES,EXISTING RENAL FAILURE INDICATED BY ELEVATED SERUM CREATININE LEVELS,CNS DISORDER CORONARY ARTERY DISEASE,THYROID DYSFUNCTION ,MALIGNANT AND ACCELERATED HYPERTENSIVE,SUBJECT THOSE WHO ARE NOT WILLING TO GIVING INFORMED CONCENT.

发起方

AYOTHIDOSS PANDITHAR HOSPITA